Saito H - Search Results

1

Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody.

Taji H, Kagami Y, Okada Y, Andou M, Nishi Y, Saito H, Seto M, Morishima Y. Taji H, et al. Among authors: saito h. Jpn J Cancer Res. 1998 Jul;89(7):748-56. doi: 10.1111/j.1349-7006.1998.tb03280.x. Jpn J Cancer Res. 1998. PMID: 9738982 Free PMC article.

2

Novel interleukin-2 dependent T-cell line derived from adult T-cell leukemia not associated with human T-cell leukemia virus type I.

Kagami Y, Tobinai K, Kinoshita T, Nagai H, Hotta T, Seto M, Ueda R, Saito H. Kagami Y, et al. Among authors: saito h. Jpn J Cancer Res. 1993 Apr;84(4):371-8. doi: 10.1111/j.1349-7006.1993.tb00146.x. Jpn J Cancer Res. 1993. PMID: 8390425 Free PMC article.

3

Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy.

Abe A, Emi N, Taji H, Kasai M, Kohno A, Saito H. Abe A, et al. Among authors: saito h. Gene Ther. 1996 Nov;3(11):988-93. Gene Ther. 1996. PMID: 8940639

4

Complementarity determining region-III is a useful molecular marker for the evaluation of minimal residual disease in mantle cell lymphoma.

Kurokawa T, Kinoshita T, Murate T, Nagasaka T, Kagami Y, Ogura M, Nakamura S, Seto M, Hotta T, Saito H. Kurokawa T, et al. Among authors: saito h. Br J Haematol. 1997 Aug;98(2):408-12. doi: 10.1046/j.1365-2141.1997.2133030.x. Br J Haematol. 1997. PMID: 9266940 Free article.

5

CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.

Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, Suchi T, Kodera Y, Morishima Y, Takahashi T, Saito H, Ueda R, Nakamura S. Suzuki R, et al. Among authors: saito h. Blood. 1997 Sep 15;90(6):2417-28. Blood. 1997. PMID: 9310493 Free article.

6

A novel human myeloid leukemia cell line, NKM-1, coexpressing granulocyte colony-stimulating factor receptors and macrophage colony-stimulating factor receptors.

Kataoka T, Morishita Y, Ogura M, Morishima Y, Towatari M, Kato Y, Inoue H, Saito H. Kataoka T, et al. Among authors: saito h. Cancer Res. 1990 Dec 1;50(23):7703-9. Cancer Res. 1990. PMID: 1701353

7

Up-regulation of transferrin receptor gene expression by granulocyte colony-stimulating factor in human myeloid leukemia cells.

Morishita Y, Kataoka T, Towatari M, Ito T, Inoue H, Ogura M, Morishima Y, Saito H. Morishita Y, et al. Among authors: saito h. Cancer Res. 1990 Dec 15;50(24):7955-61. Cancer Res. 1990. PMID: 1701357

8

Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.

Kasai M, Akatsuka Y, Emi N, Taji H, Kohno A, Abe A, Tanimoto M, Kodera Y, Saito H. Kasai M, et al. Among authors: saito h. Int J Hematol. 1999 Feb;69(2):112-8. Int J Hematol. 1999. PMID: 10071461

9

Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells.

Towatari M, Ito Y, Morishita Y, Tanimoto M, Kawashima K, Morishima Y, Andoh T, Saito H. Towatari M, et al. Among authors: saito h. Cancer Res. 1990 Nov 15;50(22):7198-202. Cancer Res. 1990. PMID: 1699657

10

Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.

Murate T, Yamashita K, Ohashi H, Kagami Y, Tsushita K, Kinoshita T, Hotta T, Saito H, Yoshida S, Mori KJ, et al. Murate T, et al. Among authors: saito h. Exp Hematol. 1993 Jan;21(1):169-76. Exp Hematol. 1993. PMID: 8417953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,644 results

Search Page

Filters